Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Oncotarget
|
August 29, 2015
EMT-induced metabolite signature identifies poor clinical outcome
Salil Kumar Bhowmik, Esmeralda Ramirez-Peña, James Michael Arnold, et al.
Archives of Pathology & Laboratory Medicine
|
February 17, 2025
Loss of H3K27me3 Is Not Specific to Malignant Triton Tumor: Immunohistochemical Analysis of 23 Cases of Embryonal Rhabdomyosarcoma
Laura M Warmke, Jessica L Davis, Alyaa Al-Ibraheemi, et al.
Pediatric Blood & Cancer
|
January 28, 2024
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Douglas J Harrison, Amira Qumseya, Wei Xue, et al.
Genes & Development
|
September 6, 2005
Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2
Osamu Nakagawa, Michael Arnold, Masayo Nakagawa, et al.
IEEE Open Journal of Engineering in Medicine and Biology
|
March 6, 2024
Expecting the Unexpected: Predicting Panic Attacks From Mood, Twitter, and Apple Watch Data
Ellen W McGinnis, Bryn Loftness, Shania Lunna, et al.
Plos Genetics
|
April 21, 2020
The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss
Bhuvana A Setty, Goodwin G Jinesh, Michael Arnold, et al.
Journal of the International AIDS Society
|
February 21, 2020
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment
Christel Protiere, Michael Arnold, Marion Fiorentino, et al.
Elife
|
February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrhea
Jana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
The Lancet. Oncology
|
June 27, 2024
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group
Abha A Gupta, Wei Xue, Douglas J Harrison, et al.
Journal of Pediatric Surgery
|
April 3, 2019
Guidelines for synoptic reporting of surgery and pathology in Hirschsprung disease
Laura V Veras, Michael Arnold, Jeffrey R Avansino, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Oncotarget
|
August 29, 2015
EMT-induced metabolite signature identifies poor clinical outcome
Salil Kumar Bhowmik, Esmeralda Ramirez-Peña, James Michael Arnold, et al.
Archives of Pathology & Laboratory Medicine
|
February 17, 2025
Loss of H3K27me3 Is Not Specific to Malignant Triton Tumor: Immunohistochemical Analysis of 23 Cases of Embryonal Rhabdomyosarcoma
Laura M Warmke, Jessica L Davis, Alyaa Al-Ibraheemi, et al.
Pediatric Blood & Cancer
|
January 28, 2024
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Douglas J Harrison, Amira Qumseya, Wei Xue, et al.
Genes & Development
|
September 6, 2005
Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2
Osamu Nakagawa, Michael Arnold, Masayo Nakagawa, et al.
IEEE Open Journal of Engineering in Medicine and Biology
|
March 6, 2024
Expecting the Unexpected: Predicting Panic Attacks From Mood, Twitter, and Apple Watch Data
Ellen W McGinnis, Bryn Loftness, Shania Lunna, et al.
Plos Genetics
|
April 21, 2020
The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss
Bhuvana A Setty, Goodwin G Jinesh, Michael Arnold, et al.
Journal of the International AIDS Society
|
February 21, 2020
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment
Christel Protiere, Michael Arnold, Marion Fiorentino, et al.
Elife
|
February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrhea
Jana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
The Lancet. Oncology
|
June 27, 2024
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group
Abha A Gupta, Wei Xue, Douglas J Harrison, et al.
Journal of Pediatric Surgery
|
April 3, 2019
Guidelines for synoptic reporting of surgery and pathology in Hirschsprung disease
Laura V Veras, Michael Arnold, Jeffrey R Avansino, et al.
Page
of 7